Event Detail (Archived)

Targeted Protein Degradation as a New Cancer Drug Strategy

Research Seminar Series

  • This event already took place in March 2019
  • Zuckerman Auditorium, MSKCC, 417 E. 68th St.

Event Details

Type
Molecular Pharmacology and Chemistry Program
Speaker(s)
Nathanael Gray, Ph.D., professor, Harvard Medical School
Open to
Public
Host
Dr. Derek Tan
Contact
Jocette Marquez
Phone
(646) 888-3709
Sponsor
Jocette Marquez
(646) 888-3709
marquezj@mskcc.org

Related News

This new, one-two punch could knock out drug-resistant TB

Researchers found that pairing the antibiotic rifampicin with a second compound turned multidrug resistance into a weakness—providing proof of concept for using basic science to design life-saving dual-drug strategies.

Hess Center for Research on Women’s Health and Biomedicine holds its inaugural symposium

Covering topics from osteoarthritis to neurodevelopment, the inaugural symposium of the Marlene Hess Center showcased research that illuminates how biological sex shapes health and disease.

A new reference brain could make the clonal raider ant a go-to model species for neuroscience  

Researchers created this first-of-its kind map by merging 40 ant brains into one.

Related Events

Brain Dynamics

| CARSON FAMILY AUDITORIUM (CRC)

Pre-Seminar Coffee and Cookies

| LOWER LEVEL GREENBERG BUILDING (CRC)

Some Observations on How AlphaFold Predicts, and Learns to Predict, Protein Structures.

| CARSON FAMILY AUDITORIUM (CRC)